Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease

Table 2

Carotid intima-media thickness, ankle-brachial index, and atherosclerotic plaque in systemic lupus erythematosus patients and healthy controls.

Assessed parameters	Systemic lupus erythematosus patients; Median (Q1, Q3)	Healthy controls; Median (Q1, Q3)
cIMT (mm)	0.70 (0.65, 0.80)	0.60 (0.60, 0.70)
ABI right	1.08 (1.03, 1.16)	1.12 (1.06, 1.24)
ABI left	1.08 (1.10, 1.17)	1.15 (1.08, 1.21)
Plaques, n (%)
cca, n (%)	3 (3.2%)	—
Bulb, n (%)	19 (20.2%)	—
ica, n (%)	2 (2.1%)	—
Carotid arteries, n (%)	22 (23.4%)	—
iliaca, n (%)	8 (8.5%)	—
cfa, n (%)	18 (19.1%)	—
dfa, n (%)	1 (1.1%)	—
sfa, n (%)	9 (9.6%)	—
popla, n (%)	4 (4.3%)	—
pta, n (%)	1 (1.1%)	—
Lower extremity arteries, n (%)	27 (28.7%)	—

cIMT: carotid intima-media thickness; ABI: ankle-brachial index; cca: common carotid arteries; ica: internal carotid arteries; iliaca: iliac arteries; cfa: common femoral arteries; dfa: deep femoral arteries; sfa: superficial femoral arteries; popla: popliteal arteries; pta: posterior tibial arteries.